IMMUNE CHECKPOINT INHIBITORS
Clinical trials for IMMUNE CHECKPOINT INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITORS trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost bladder cancer surgery success
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy before and after bladder removal surgery is safe and tolerable for people with muscle-invasive bladder cancer. About 150 participants will receive durvalumab alongside either of two chemoth…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug combo shows promise in shrinking stomach tumors before surgery
Disease control Recruiting nowThis study tests whether adding the drug serplulimab to standard chemotherapy before and after surgery helps people with advanced stomach or gastroesophageal junction cancer. About 116 adults will be randomly assigned to receive either the combination or chemotherapy alone. The m…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Phase: PHASE2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Could immune drugs help fight persistent brain viruses?
Knowledge-focused Recruiting nowThis study follows 66 people with chronic viral infections of the brain, such as PML, to see if giving immune checkpoint inhibitors can improve their long-term recovery. Researchers will track disability, brain scans, and virus levels over one year. The goal is to understand whet…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:37 UTC
-
New study explores painful joint side effects of cancer immunotherapy
Knowledge-focused Recruiting nowThis study aims to understand how severe and life-altering rheumatic side effects (like arthritis) can be for people receiving immune checkpoint inhibitor therapy for cancer. Researchers will interview 20 English-speaking adults who have been diagnosed with these side effects by …
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 03:36 UTC